Olesen et al., 2005 [28] |
21 type 1/type 2 patients |
Increased OPG levels in the aortic tunica media are associated with vascular calcifications |
Browner et al., 2001 [37] |
35 type 2 patients |
OPG is associated with cardiovascular mortality |
Avignon et al., 2007 [51] |
465 type 1/type 2 patients |
OPG is associated with silent myocardial ischemia |
Rasmussen et al., 2006 [52] |
400 type 1 patients |
OPG is associated with poor glycemic control and CVD |
Blazquez-Medela et al., 2012 [53] |
52 type 2 patients |
OPG is an indicator of endothelial dysfunction and CVD risk |
Altinova et al., 2011 [57] |
166 type 2 patients |
OPG is associated with poor glycemic control and microalbuminuria |
Grauslund et al., 2010 [58] |
200 type 1 patients |
OPG is associated with nephropathy |
Poulsen et al., 2011 [61] |
735 type 2 patients |
OPG is associated with carotid and peripheral arterial disease |
Ishiyama et al., 2009 [62] |
168 type 2 patients |
OPG is positively associated with vascular calcifications and CIMT |
Shin et al., 2006 [63] |
104 type 2 patients |
OPG levels are associated with endothelial dysfunction |
Terekeci et al., 2009 [64] |
42 type 2 patients |
OPG levels are associated with neuropathy |
Xiang et al., 2007 [70] |
22 type 1 patients |
OPG are associated with endothelial function |